Cargando…

Characteristics of circulating KSHV-infected viroblasts during active KSHV(+) multicentric Castleman disease

Kaposi sarcoma–associated herpesvirus (KSHV)/human herpesvirus 8–associated multicentric Castleman disease (MCD) is a polyclonal B-cell lymphoproliferative disorder that mainly occurs in immunocompromised hosts. The diagnosis relies on lymph node biopsy demonstrating KSHV-infected cells located in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin de Frémont, Gregoire, Vanjak, Anthony, Sbihi, Zineb, Knapp, Silene, Garzaro, Margaux, Chbihi, Marwa, Fournier, Benjamin, Poirot, Justine, Dossier, Antoine, Silvestrini, Marc-Antoine, Villemonteix, Juliette, Meignin, Véronique, Galicier, Lionel, Bertinchamp, Rémi, Le Goff, Jerome, Salmona, Maud, Flamarion, Edouard, Cassius, Charles, Lebbé, Celeste, Ronchetti, Anne Marie, Latour, Sylvain, Oksenhendler, Eric, Carcelain, Guislaine, Boutboul, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182301/
https://www.ncbi.nlm.nih.gov/pubmed/36508281
http://dx.doi.org/10.1182/bloodadvances.2022008456
_version_ 1785041742258503680
author Martin de Frémont, Gregoire
Vanjak, Anthony
Sbihi, Zineb
Knapp, Silene
Garzaro, Margaux
Chbihi, Marwa
Fournier, Benjamin
Poirot, Justine
Dossier, Antoine
Silvestrini, Marc-Antoine
Villemonteix, Juliette
Meignin, Véronique
Galicier, Lionel
Bertinchamp, Rémi
Le Goff, Jerome
Salmona, Maud
Flamarion, Edouard
Cassius, Charles
Lebbé, Celeste
Ronchetti, Anne Marie
Latour, Sylvain
Oksenhendler, Eric
Carcelain, Guislaine
Boutboul, David
author_facet Martin de Frémont, Gregoire
Vanjak, Anthony
Sbihi, Zineb
Knapp, Silene
Garzaro, Margaux
Chbihi, Marwa
Fournier, Benjamin
Poirot, Justine
Dossier, Antoine
Silvestrini, Marc-Antoine
Villemonteix, Juliette
Meignin, Véronique
Galicier, Lionel
Bertinchamp, Rémi
Le Goff, Jerome
Salmona, Maud
Flamarion, Edouard
Cassius, Charles
Lebbé, Celeste
Ronchetti, Anne Marie
Latour, Sylvain
Oksenhendler, Eric
Carcelain, Guislaine
Boutboul, David
author_sort Martin de Frémont, Gregoire
collection PubMed
description Kaposi sarcoma–associated herpesvirus (KSHV)/human herpesvirus 8–associated multicentric Castleman disease (MCD) is a polyclonal B-cell lymphoproliferative disorder that mainly occurs in immunocompromised hosts. The diagnosis relies on lymph node biopsy demonstrating KSHV-infected cells located in the mantle zone with a marked interfollicular plasma cell infiltration. Infected cells are large cells positive for immunoglobulin M (IgM), λ light chain, and CD38, described initially as infected plasmablasts. We show that IgM(+)λ(+)CD38(high) cells were also detectable in the peripheral blood of 14 out of 18 (78%) patients with active KSHV-MCD and absent in 40 controls. Using immunofluorescence and flow–fluorescence in situ hybridization, we demonstrate that these cells are KSHV infected and express both latent and lytic KSHV transcripts. These KSHV-infected viroblasts (KIVs) harbor a distinct phenotype compared with conventional plasmablasts. We also identified several putative mechanisms of immune escape used by KSHV, because KIVs displayed an overall decrease of costimulatory molecules, with a remarkable lack of CD40 expression and are interleukin-10–producing cells. The identification of this specific and easily accessible KSHV(+) circulating population brings new elements to the understanding of KSHV-MCD but also raises new questions that need to be clarified.
format Online
Article
Text
id pubmed-10182301
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-101823012023-05-14 Characteristics of circulating KSHV-infected viroblasts during active KSHV(+) multicentric Castleman disease Martin de Frémont, Gregoire Vanjak, Anthony Sbihi, Zineb Knapp, Silene Garzaro, Margaux Chbihi, Marwa Fournier, Benjamin Poirot, Justine Dossier, Antoine Silvestrini, Marc-Antoine Villemonteix, Juliette Meignin, Véronique Galicier, Lionel Bertinchamp, Rémi Le Goff, Jerome Salmona, Maud Flamarion, Edouard Cassius, Charles Lebbé, Celeste Ronchetti, Anne Marie Latour, Sylvain Oksenhendler, Eric Carcelain, Guislaine Boutboul, David Blood Adv Immunobiology and Immunotherapy Kaposi sarcoma–associated herpesvirus (KSHV)/human herpesvirus 8–associated multicentric Castleman disease (MCD) is a polyclonal B-cell lymphoproliferative disorder that mainly occurs in immunocompromised hosts. The diagnosis relies on lymph node biopsy demonstrating KSHV-infected cells located in the mantle zone with a marked interfollicular plasma cell infiltration. Infected cells are large cells positive for immunoglobulin M (IgM), λ light chain, and CD38, described initially as infected plasmablasts. We show that IgM(+)λ(+)CD38(high) cells were also detectable in the peripheral blood of 14 out of 18 (78%) patients with active KSHV-MCD and absent in 40 controls. Using immunofluorescence and flow–fluorescence in situ hybridization, we demonstrate that these cells are KSHV infected and express both latent and lytic KSHV transcripts. These KSHV-infected viroblasts (KIVs) harbor a distinct phenotype compared with conventional plasmablasts. We also identified several putative mechanisms of immune escape used by KSHV, because KIVs displayed an overall decrease of costimulatory molecules, with a remarkable lack of CD40 expression and are interleukin-10–producing cells. The identification of this specific and easily accessible KSHV(+) circulating population brings new elements to the understanding of KSHV-MCD but also raises new questions that need to be clarified. The American Society of Hematology 2022-12-15 /pmc/articles/PMC10182301/ /pubmed/36508281 http://dx.doi.org/10.1182/bloodadvances.2022008456 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Immunobiology and Immunotherapy
Martin de Frémont, Gregoire
Vanjak, Anthony
Sbihi, Zineb
Knapp, Silene
Garzaro, Margaux
Chbihi, Marwa
Fournier, Benjamin
Poirot, Justine
Dossier, Antoine
Silvestrini, Marc-Antoine
Villemonteix, Juliette
Meignin, Véronique
Galicier, Lionel
Bertinchamp, Rémi
Le Goff, Jerome
Salmona, Maud
Flamarion, Edouard
Cassius, Charles
Lebbé, Celeste
Ronchetti, Anne Marie
Latour, Sylvain
Oksenhendler, Eric
Carcelain, Guislaine
Boutboul, David
Characteristics of circulating KSHV-infected viroblasts during active KSHV(+) multicentric Castleman disease
title Characteristics of circulating KSHV-infected viroblasts during active KSHV(+) multicentric Castleman disease
title_full Characteristics of circulating KSHV-infected viroblasts during active KSHV(+) multicentric Castleman disease
title_fullStr Characteristics of circulating KSHV-infected viroblasts during active KSHV(+) multicentric Castleman disease
title_full_unstemmed Characteristics of circulating KSHV-infected viroblasts during active KSHV(+) multicentric Castleman disease
title_short Characteristics of circulating KSHV-infected viroblasts during active KSHV(+) multicentric Castleman disease
title_sort characteristics of circulating kshv-infected viroblasts during active kshv(+) multicentric castleman disease
topic Immunobiology and Immunotherapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182301/
https://www.ncbi.nlm.nih.gov/pubmed/36508281
http://dx.doi.org/10.1182/bloodadvances.2022008456
work_keys_str_mv AT martindefremontgregoire characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT vanjakanthony characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT sbihizineb characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT knappsilene characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT garzaromargaux characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT chbihimarwa characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT fournierbenjamin characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT poirotjustine characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT dossierantoine characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT silvestrinimarcantoine characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT villemonteixjuliette characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT meigninveronique characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT galicierlionel characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT bertinchampremi characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT legoffjerome characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT salmonamaud characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT flamarionedouard characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT cassiuscharles characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT lebbeceleste characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT ronchettiannemarie characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT latoursylvain characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT oksenhendlereric characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT carcelainguislaine characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease
AT boutbouldavid characteristicsofcirculatingkshvinfectedviroblastsduringactivekshvmulticentriccastlemandisease